Cambridge, United Kingdom

Michael James Herd

This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael James Herd. Retrieved from https://idiyas.com/inventor/michael-james-herd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael James Herd: Innovator in Medical Technology

Introduction

Michael James Herd is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of medical technology, particularly with his innovative designs and solutions. His work has the potential to impact healthcare positively.

Latest Patents

Michael holds a patent for a medical injector, showcasing his commitment to advancing medical devices. This invention reflects his dedication to improving patient care and treatment methods.

Career Highlights

Michael is currently employed at AstraZeneca Ab, a leading global biopharmaceutical company. His role there allows him to work on cutting-edge medical technologies and collaborate with other experts in the field.

Collaborations

Michael has worked alongside talented individuals such as Thomas James Etheridge and Kathryn Anna Thompson. These collaborations have likely enriched his work and contributed to the success of his projects.

Conclusion

Michael James Herd is a prominent figure in the realm of medical innovation, with a focus on developing technologies that enhance healthcare. His contributions, particularly in the area of medical injectors, demonstrate his commitment to improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…